All4NutraNo products in the cart.
All4NutraStartseite » Suppliers » Hayashibara » Page 3
Ketoconazole (K) is a poorly water-soluble drug that faces significant challenges in achieving therapeutic efficacy. This study aimed to enhance...
Abstract As of 2023, more than 200 million people worldwide are living with osteoporosis. Oral bisphosphonates (BPs) are the primary...
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) continue as public health concerns. Inhaled drug therapy for TB has substantial...
Abstract Biopharmaceuticals are labile biomolecules that must be safeguarded to ensure the safety, quality, and efficacy of the product. Batch...
SOLBIOTE (TM) – Injectable-grade Saccharide Excipients for Biopharmaceuticals Nagase Viita, the first company in the world to mass produce Trehalose, has...
Nagase Viita Co., Ltd. (Headquarters: Shimoishii, Kita-ku, Okayama; Representative Director: Naoki Yasuba), a member of the NAGASE Group, has launched...
Founded as a starch syrup manufacturer in 1883, Nagase Viita (Formerly Hayashibara Co., Ltd.) has grown into a company with strong...
PRESS RELEASE April 2, 2024 Nagase Viita Co., Ltd. (Headquarters: Kita-ku, Okayama; Representative Director: Naoki Yasuba), a member of the...
Reversible protein precipitates (protein microbeads) have been developed using Shirasu porous glass (SPG) membrane emulsification. Microbeads have a mean size...
PRESS RELEASE April, 2024 Our origins date back to when sweet foods held great value, and our company crafted syrup...
Copyright: PharmaExcipients AG